Tweet Archive for May 2018 « page 12
RT @SergioVanoG: En 20 minutos empezamos el taller interactivo de formación en Twitter!!!!!!
#AulaLilly @LillyES #AEDV2018 #AEDV18 https://…
RT @EczemaPhoenix: So happy that ethnicity is being incorporated into the eczema dialogue!
#EczemaAwareness – Atopic dermatitis in diverse racial and ethnic groups – Variations in epidemiology, genetics, clinical presentation and treatment https://t.co/IxRp38Z4bx #dermatology #dermatologia #eczema pic.twitter.com/PrjKj7b57E
— Dominique du Crest (@ducrest) May 11, 2018
#EczemaAwareness – Atopic dermatitis in diverse racial and ethnic groups – Variations in epidemiology, genetics, cl…
https://twitter.com/i/web/status/994845695956877313
Interleukin‐31 and interleukin‐31 receptor: New therapeutic targets for atopic dermatitis onlinelibrary.wiley.com/doi/abs/10.111……
https://twitter.com/i/web/status/994844639571177472
Genetic Customization of Anti-aging Treatments via @OmicsJournal
omicsonline.org/open-access/ge… #genes #cosmetics #dermatology
Fringe benefits: Drug side effects could treat human #hairloss sciencedaily.com/releases/2018/… #dermatology #dermatologia
Botulinum Toxin in Aesthetic Medicine: Myths and Realities ncbi.nlm.nih.gov/pubmed/29016535 #cosmetic #dermatology #dermatologia
Polyalkylimide: A Nonstable Filler Over Time ncbi.nlm.nih.gov/pubmed/29059143 #dermalfiller #cosmetic #dermatology #dermatologia
Resveratrol as an active ingredient for cosmetic and dermatological applications: a review ncbi.nlm.nih.gov/pubmed/29737899…
https://twitter.com/i/web/status/994683685336178689
Krystal Biotech Announces Dosing of First Patient in the Phase 1/2 trial of KB103, a First-in-Class Topical Gene Th…
https://twitter.com/i/web/status/994630560835428353